Emilie Cloatre, Martyn Pickersgill, Caesar A Atuire, Mairead Enright, Phoebe Friesen, Patricia Kingori, Tidiane Ndoye, Nayeli Urquiza-Haas
{"title":"States, law, and the regulation of controversial health-related claims: consolidating a research agenda between disciplines and contexts.","authors":"Emilie Cloatre, Martyn Pickersgill, Caesar A Atuire, Mairead Enright, Phoebe Friesen, Patricia Kingori, Tidiane Ndoye, Nayeli Urquiza-Haas","doi":"10.12688/wellcomeopenres.24597.1","DOIUrl":null,"url":null,"abstract":"<p><p>Stories of unproven, disproven, or misleading health-related claims, and their impact on individual and public health, are commonplace around the world. Disquiet about such claims is ubiquitous and growing within public, clinical, scientific, and policy discourse, with law commonly presented as having an important role to play in addressing concerns. Action, though, requires regulators to account for competing considerations, including fundamental freedoms, cultural diversity, and the potential for law to exacerbate inequalities. The latter is particularly significant when assessing the veracity of marginalised beliefs. In practice, legal decision-makers walk a fine line between everyday tolerance and occasional intervention. Yet, legal research pertinent to these issues is surprisingly limited. Here, we argue that new knowledge, methods, and collaborations are needed to better understand how regulatory interventions relevant to contested claims are constituted; how they operate in practice; and how they relate to different political and social processes - including acts of public resistance (like campaigns and protests). Only once we are collectively equipped with such critical knowledge of the current nature and possibilities of regulatory relations will it be possible to collectively design more imaginative and inclusive legal responses.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"10 ","pages":"414"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12449687/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wellcome Open Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/wellcomeopenres.24597.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Stories of unproven, disproven, or misleading health-related claims, and their impact on individual and public health, are commonplace around the world. Disquiet about such claims is ubiquitous and growing within public, clinical, scientific, and policy discourse, with law commonly presented as having an important role to play in addressing concerns. Action, though, requires regulators to account for competing considerations, including fundamental freedoms, cultural diversity, and the potential for law to exacerbate inequalities. The latter is particularly significant when assessing the veracity of marginalised beliefs. In practice, legal decision-makers walk a fine line between everyday tolerance and occasional intervention. Yet, legal research pertinent to these issues is surprisingly limited. Here, we argue that new knowledge, methods, and collaborations are needed to better understand how regulatory interventions relevant to contested claims are constituted; how they operate in practice; and how they relate to different political and social processes - including acts of public resistance (like campaigns and protests). Only once we are collectively equipped with such critical knowledge of the current nature and possibilities of regulatory relations will it be possible to collectively design more imaginative and inclusive legal responses.
Wellcome Open ResearchBiochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
5.50
自引率
0.00%
发文量
426
审稿时长
1 weeks
期刊介绍:
Wellcome Open Research publishes scholarly articles reporting any basic scientific, translational and clinical research that has been funded (or co-funded) by Wellcome. Each publication must have at least one author who has been, or still is, a recipient of a Wellcome grant. Articles must be original (not duplications). All research, including clinical trials, systematic reviews, software tools, method articles, and many others, is welcome and will be published irrespective of the perceived level of interest or novelty; confirmatory and negative results, as well as null studies are all suitable. See the full list of article types here. All articles are published using a fully transparent, author-driven model: the authors are solely responsible for the content of their article. Invited peer review takes place openly after publication, and the authors play a crucial role in ensuring that the article is peer-reviewed by independent experts in a timely manner. Articles that pass peer review will be indexed in PubMed and elsewhere. Wellcome Open Research is an Open Research platform: all articles are published open access; the publishing and peer-review processes are fully transparent; and authors are asked to include detailed descriptions of methods and to provide full and easy access to source data underlying the results to improve reproducibility.